deltatrials
Unknown PHASE4 INTERVENTIONAL 3-arm NCT04225312

Personalized Extended Interval Dosing of Natalizumab in Relapsing Remitting Multiple Sclerosis (SUPERNEXT)

Sponsor: Amsterdam UMC, location VUmc

Updated 10 times since 2020 Last updated: Apr 25, 2023 Started: Feb 3, 2020 Primary completion: Mar 1, 2025 Completion: Mar 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Relapsing Remitting Multiple Sclerosis, this trial is ongoing. The trial is conducted by Amsterdam UMC, location VUmc and has accumulated 10 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Feb 2020 – ~Jun 2020 · 4 months · monthly snapshot~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshotRecruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotRecruiting~Oct 2021 – ~May 2022 · 7 months · monthly snapshotRecruiting~May 2022 – ~May 2023 · 12 months · monthly snapshotRecruiting~May 2023 – ~Jul 2024 · 14 months · monthly snapshotEnrolling By Invitation~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~May 2025 · 8 months · monthly snapshotEnrolling By Invitation~May 2025 – ~Sep 2025 · 4 months · monthly snapshot~Sep 2025 – present · 11 months · monthly snapshotUnknown

Change History

10 versions recorded
  1. Sep 2025 — Present [monthly]

    Unknown PHASE4

  2. May 2025 — Sep 2025 [monthly]

    Unknown PHASE4

    Status: Enrolling By InvitationUnknown

  3. Sep 2024 — May 2025 [monthly]

    Enrolling By Invitation PHASE4

  4. Jul 2024 — Sep 2024 [monthly]

    Enrolling By Invitation PHASE4

  5. May 2023 — Jul 2024 [monthly]

    Enrolling By Invitation PHASE4

    Status: RecruitingEnrolling By Invitation

Show 5 earlier versions
  1. May 2022 — May 2023 [monthly]

    Recruiting PHASE4

  2. Oct 2021 — May 2022 [monthly]

    Recruiting PHASE4

  3. Jan 2021 — Oct 2021 [monthly]

    Recruiting PHASE4

  4. Jun 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

  5. Feb 2020 — Jun 2020 [monthly]

    Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Amsterdam UMC, location VUmc
  • Innovatiefonds Zorgverzekeraars
  • Stichting MS Research
  • Stichting Treatmeds
Data source: Amsterdam UMC, location VUmc

For direct contact, visit the study record on ClinicalTrials.gov .